ARROWHEAD PHARMACEUTICALS, INC. ARWR
ARROWHEAD PHARMACEUTICALS, INC. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 15,683,206 | $407.6M | 11.07% |
| TWO SIGMA INVESTMENTS, LP | 580,609 | $47.3M | 0.41% |
| D. E. Shaw & Co., Inc. | 431,560 | $35.2M | 0.3% |
| MILLENNIUM MANAGEMENT LLC | 407,537 | $33.2M | 0.29% |
| CITADEL ADVISORS LLC | 326,000 | $26.6M | 0.23% |
| AQR CAPITAL MANAGEMENT LLC | 198,842 | $15.8M | 0.14% |
| Point72 Asset Management, L.P. | 39,900 | $3.3M | 0.03% |
| RENAISSANCE TECHNOLOGIES LLC | 34,000 | $2.2M | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.